InfinixBio, Formed From the Merger of Molecular Technologies Laboratories (MTL) and Applied Biomolecular Technologies, Inc. - Creating a Biotech Engine to Accelerate Technology Commercialization

COLUMBUS, Ohio, /PRNewswire/ -- On December 31, 2018, Molecular Technologies Laboratories and Applied Biomolecular Technologies, Inc., completed their merger transaction by integrating their services under its new company name, InfinixBio. The merger builds on a strong partnership the two companies established in 2012, working together to provide complementary and innovative solutions in genetic engineering, protein biochemistry, microbiology and cell biology.

“The newly formed company, InfinixBio, is in the business of helping clients advance and commercialize biotechnology and develop better bio-products. Through the merging of these two great companies, we can now offer a broad range of integrated services that deliver greater value to our clients,” says Nick Henderson, CEO of InfinixBio. “Our goal is to be the world leader in the outsourced lab biotechnology commercialization space. The merger of Molecular Technologies Laboratories and Applied Biomolecular Technologies, Inc., gets us a step closer to being recognized as the unmatched biotech leader, capable of solving the most difficult problems in biotech product development and commercialization,” stated Henderson.

InfinixBio has locations in Columbus and Athens, Ohio, with over 30 scientists operating in three labs. By working closely with entrepreneurs, investors, biotechnology companies and contract research organizations, InfinixBio is able to provide customized solutions that accelerate the development of new or existing technologies.

About InfinixBio
InfinixBio is a biotech company run by entrepreneurs focused on creating value and achieving customer driven milestones. Our team of business-savvy scientists and bio-experts help investors, entrepreneurs and biotech companies solve problems and achieve milestones. InfinixBio is a hands-on laboratory that helps companies in 3 ways:

1. Developing products from existing technologies (creating a path to move from lab to market)
2. Improving existing technologies (focused on efficiency, performance, scale up, and cost)
3. Creating new markets, from existing products and technologies (adapting products for new uses)

InfinixBio accelerates research and development by providing creative solutions in the areas of genetic engineering, protein biochemistry, microbiology and cell biology.

For more information, please contact info@InfinixBio.com or visit www.InfinixBio.com

Media Contact:
Jeff Houtz
208596@email4pr.com
(740)444-9050

View original content to download multimedia:http://www.prnewswire.com/news-releases/infinixbio-formed-from-the-merger-of-molecular-technologies-laboratories-mtl-and-applied-biomolecular-technologies-inc--creating-a-biotech-engine-to-accelerate-technology-commercialization-300791145.html

SOURCE InfinixBio